Lepu Medical Tech Beijing (300003) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lepu Medical Tech Beijing (300003) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.84 Million ≈ $62.31 Million USD) by net assets (CN¥17.75 Billion ≈ $2.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300003 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Lepu Medical Tech Beijing - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Lepu Medical Tech Beijing's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lepu Medical Tech Beijing Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lepu Medical Tech Beijing ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang XinAn Chemical Industrial Group Co Ltd
SHG:600596
|
0.018x |
|
Procter & Gamble Hygiene and Health Care Limited
NSE:PGHH
|
0.688x |
|
Ardentec
TWO:3264
|
0.049x |
|
Trigano S.A.
PA:TRI
|
0.204x |
|
Highwoods Properties Inc
NYSE:HIW
|
0.024x |
|
TOMRA SYSTEMS ADR/1 NK 1
F:TMR0
|
0.094x |
|
Standex International Corporation
NYSE:SXI
|
0.028x |
|
China Communications Construction Company Limited
F:CYY
|
-0.051x |
Annual Cash Flow Conversion Efficiency for Lepu Medical Tech Beijing (2006–2025)
The table below shows the annual cash flow conversion efficiency of Lepu Medical Tech Beijing from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Lepu Medical Tech Beijing.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥17.76 Billion ≈ $2.60 Billion |
CN¥1.52 Billion ≈ $221.97 Million |
0.085x | +94.63% |
| 2024-12-31 | CN¥16.74 Billion ≈ $2.45 Billion |
CN¥734.64 Million ≈ $107.50 Million |
0.044x | -22.47% |
| 2023-12-31 | CN¥17.50 Billion ≈ $2.56 Billion |
CN¥990.36 Million ≈ $144.92 Million |
0.057x | -66.80% |
| 2022-12-31 | CN¥16.37 Billion ≈ $2.40 Billion |
CN¥2.79 Billion ≈ $408.37 Million |
0.170x | -31.67% |
| 2021-12-31 | CN¥12.27 Billion ≈ $1.80 Billion |
CN¥3.06 Billion ≈ $448.07 Million |
0.249x | +25.80% |
| 2020-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
CN¥2.09 Billion ≈ $305.79 Million |
0.198x | -20.24% |
| 2019-12-31 | CN¥8.00 Billion ≈ $1.17 Billion |
CN¥1.99 Billion ≈ $291.24 Million |
0.249x | +8.96% |
| 2018-12-31 | CN¥6.58 Billion ≈ $962.28 Million |
CN¥1.50 Billion ≈ $219.57 Million |
0.228x | +75.60% |
| 2017-12-31 | CN¥7.03 Billion ≈ $1.03 Billion |
CN¥913.13 Million ≈ $133.62 Million |
0.130x | +12.93% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.94 Million |
CN¥691.89 Million ≈ $101.25 Million |
0.115x | +40.74% |
| 2015-12-31 | CN¥5.34 Billion ≈ $781.21 Million |
CN¥436.46 Million ≈ $63.87 Million |
0.082x | -22.72% |
| 2014-12-31 | CN¥3.29 Billion ≈ $481.81 Million |
CN¥348.32 Million ≈ $50.97 Million |
0.106x | -7.14% |
| 2013-12-31 | CN¥2.89 Billion ≈ $423.55 Million |
CN¥329.76 Million ≈ $48.25 Million |
0.114x | +12.59% |
| 2012-12-31 | CN¥2.62 Billion ≈ $383.16 Million |
CN¥264.96 Million ≈ $38.77 Million |
0.101x | -18.63% |
| 2011-12-31 | CN¥2.34 Billion ≈ $342.64 Million |
CN¥291.20 Million ≈ $42.61 Million |
0.124x | -31.34% |
| 2010-12-31 | CN¥2.07 Billion ≈ $302.36 Million |
CN¥374.25 Million ≈ $54.76 Million |
0.181x | +32.64% |
| 2009-12-31 | CN¥1.76 Billion ≈ $256.95 Million |
CN¥239.79 Million ≈ $35.09 Million |
0.137x | -62.98% |
| 2008-12-31 | CN¥511.23 Million ≈ $74.81 Million |
CN¥188.59 Million ≈ $27.60 Million |
0.369x | +130.77% |
| 2007-12-31 | CN¥383.88 Million ≈ $56.17 Million |
CN¥61.37 Million ≈ $8.98 Million |
0.160x | -68.34% |
| 2006-12-31 | CN¥115.51 Million ≈ $16.90 Million |
CN¥58.32 Million ≈ $8.53 Million |
0.505x | -- |
About Lepu Medical Tech Beijing
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more